SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001609351-16-000035
Filing Date
2016-05-04
Accepted
2016-05-04 16:24:46
Documents
2
Period of Report
2016-05-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_146239346335671.html 3  
1 FORM 3 wf-form3_146239346335671.xml 3 8076
2 POWER OF ATTORNEY FOR JOSEPH LA BARGE sparkpoaforjlabarge.htm EX-24 9927
  Complete submission text file 0001609351-16-000035.txt   19414
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Issuer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address
La Barge Joseph (Reporting) CIK: 0001673526 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36819 | Film No.: 161619721